Uncommon
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Uncommon, a Cambridge, UK-based company founded in 2018 as Higher Steaks, developed cultivated pork from animal cell cultures to address health, environmental and animal-welfare challenges. Its patent-pending platform sped up cell differentiation for cultivated meat. In June 2023 it raised a $30 million Series A led by Balderton Capital and Lowercarbon Capital and rebranded as Uncommon. In August 2025 Dutch company Meatable acquired its cultivated-meat platform, including technology, IP, cell lines and key staff, while Uncommon shifted toward therapeutics.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company founded
The company is founded in Cambridge as Higher Steaks to develop cultivated pork.
- Peak funding round
In June 2023 it raises a $30 million Series A led by Balderton Capital and Lowercarbon Capital and rebrands as Uncommon.
- Acquisition
In August 2025 Meatable acquires Uncommon Bio's cultivated-meat platform for an undisclosed sum; Uncommon pivots to therapeutics.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.